Marquette Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.24K Sell
80
-61
-43% -$5.11K ﹤0.01% 371
2026
Q1
$11.3K Sell
141
-8
-5% -$660 ﹤0.01% 231
2025
Q4
$12.7K Buy
149
+69
+86% +$5.66K ﹤0.01% 202
2025
Q3
$6.22K Buy
+80
New +$6.25K ﹤0.01% 295
2023
Q4
Sell
-171
Closed -$11.8K 232
2023
Q3
$11.8K Sell
171
-39
-19% -$3.13K ﹤0.01% 211
2023
Q2
$19.8K Buy
+210
New +$18.3K ﹤0.01% 189
2022
Q3
Sell
-5
Closed 285
2022
Q2
$0 Sell
5
-2,713
-100% -$281K ﹤0.01% 340
2022
Q1
$320K Buy
2,718
+6
+0.2% +$673 0.07% 74
2021
Q4
$351K Hold
2,712
0.07% 73
2021
Q3
$307K Hold
2,712
0.07% 75
2021
Q2
$281K Hold
2,712
0.06% 74
2021
Q1
$227K Hold
2,712
0.05% 83
2020
Q4
$247K Hold
2,712
0.06% 76
2020
Q3
$216K Hold
2,712
0.06% 65
2020
Q2
$187K Hold
2,712
0.06% 75
2020
Q1
$171K Hold
2,712
0.07% 74
2019
Q4
$211K Hold
2,712
0.07% 70
2019
Q3
$199K Hold
2,712
0.07% 76
2019
Q2
$167K Hold
2,712
0.06% 75
2019
Q1
$173K Buy
+2,712
New +$155K 0.06% 74

Other funds holding EW

Marquette Asset Management's EW Position: Q2 2026 in Review

Marquette Asset Management reduced its Edwards Lifesciences (EW) stake by 43% in Q2 2026, selling an estimated $5.11K and leaving 80 shares worth $7.24K. The position accounts for ﹤0.01% of the portfolio, ranked #371.

Marquette Asset Management first reported a position in EW in Q1 2019 and has held it in 20 quarters since. The position peaked at $351K in Q4 2021. 561 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Marquette Asset Management held 80 shares of Edwards Lifesciences worth $7.24K as of Q2 2026.
  • Marquette Asset Management sold 61 Edwards Lifesciences shares in Q2 2026, an estimated $5.11K.
  • Edwards Lifesciences made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #371 holding.
  • Marquette Asset Management first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 20 quarters since.
  • Marquette Asset Management's Edwards Lifesciences position peaked at $351K in Q4 2021.
  • 561 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.